产品药物是 ACE 抑制剂.

Central serotonergic agents raise the repetitive extrasystole threshold of the vulnerable period of the canine ventricular myocardium.

Circulation research·1979

Central neurochemical factors related to serotonin metabolism and cardiac ventricular vulnerability for repetitive electrical activity.

The American journal of cardiology·1978

Neural and psychologic mechanisms and the problem of sudden cardiac death.

The American journal of cardiology·1977

Muscarinic effects of vagosympathetic trunk stimulation on the repetitive extrasystole (RE) threshold.

Circulation·1976

Transforming Pulmonary Arterial Hypertension: Key Milestones and Future Perspectives.

Circulation·2026

Scaled Multidimensional Assays of Variant Effect Identify Sequence-Function Relationships in Hypertrophic Cardiomyopathy.

Circulation·2026

Exercise Training in High-Risk Populations: A Scientific Statement From the American Heart Association.

Circulation·2026

Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy: A Scientific Statement From the American Heart Association.

Circulation·2026

Cardiovascular Risk Reduction With GLP-1 RA Drugs.

Circulation·2026

Discovery of Anti-Japanese Encephalitis Compounds: Based on Natural Compound Library, Bioinformatics, Network Pharmacology and Experimental Validation.

Current pharmaceutical design·2026

Steroids from <i>Talaromyces stipitatus</i> as potential hepatocellular carcinoma inhibitors: A computational study.

Molecular biology research communications·2026

AI-driven drug discovery using transformer-based molecular representation learning.

Frontiers in artificial intelligence·2026

Molecular and metabolic dysregulation of lung cancer in developing anti-tumor activity by gambogic acid mediated mTOR signaling: in vitro and computational study.

3 Biotech·2026

The Substitute Groups in FDA-Approved Small Molecule Drugs in 2020 - 2024.

Current medicinal chemistry·2026

Multi-Target Synergy of Coridius chinensis in Testicular Aging via Network Pharmacology-Metabolomics Integration.

Current medicinal chemistry·2026

相关实验视频

产品药物是 ACE 抑制剂.

相关概念视频

Central serotonergic agents raise the repetitive extrasystole threshold of the vulnerable period of the canine ventricular myocardium.

Central neurochemical factors related to serotonin metabolism and cardiac ventricular vulnerability for repetitive electrical activity.

Neural and psychologic mechanisms and the problem of sudden cardiac death.

Muscarinic effects of vagosympathetic trunk stimulation on the repetitive extrasystole (RE) threshold.

Transforming Pulmonary Arterial Hypertension: Key Milestones and Future Perspectives.

Scaled Multidimensional Assays of Variant Effect Identify Sequence-Function Relationships in Hypertrophic Cardiomyopathy.

Exercise Training in High-Risk Populations: A Scientific Statement From the American Heart Association.

Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy: A Scientific Statement From the American Heart Association.

Cardiovascular Risk Reduction With GLP-1 RA Drugs.

Discovery of Anti-Japanese Encephalitis Compounds: Based on Natural Compound Library, Bioinformatics, Network Pharmacology and Experimental Validation.

Steroids from <i>Talaromyces stipitatus</i> as potential hepatocellular carcinoma inhibitors: A computational study.

AI-driven drug discovery using transformer-based molecular representation learning.

Molecular and metabolic dysregulation of lung cancer in developing anti-tumor activity by gambogic acid mediated mTOR signaling: in vitro and computational study.

The Substitute Groups in FDA-Approved Small Molecule Drugs in 2020 - 2024.

Multi-Target Synergy of Coridius chinensis in Testicular Aging via Network Pharmacology-Metabolomics Integration.

相关实验视频

产品药物是 ACE 抑制剂.

相关概念视频

相关文章